share_log

Keybanc Maintains Overweight on Codex DNA, Lowers Price Target to $5

Keybanc Maintains Overweight on Codex DNA, Lowers Price Target to $5

KeyBanc维持增持Codex DNA,将目标价下调至5美元
Benzinga Real-time News ·  2022/11/09 04:51

Keybanc analyst Paul Knight maintains Codex DNA (NASDAQ:DNAY) with a Overweight and lowers the price target from $8 to $5.

KeyBanc分析师保罗·奈特维持Codex DNA(纳斯达克:DNAY)的增持,并将目标价从8美元下调至5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发